#1 Clinical Trials Search in Europe

Clinical Trials By Country

Explore medical research studies available worldwide

Austria

1000+ trials
100+ centers
Latest trial:
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

Belgium

1900+ trials
200+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Bulgaria

700+ trials
300+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Croatia

200+ trials
49 centers
Latest trial:
A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

Cyprus

16 trials
5 centers
Latest trial:
A study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy

Czechia

1300+ trials
400+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Denmark

1300+ trials
67 centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Estonia

100+ trials
30 centers
Latest trial:
A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Finland

400+ trials
92 centers
Latest trial:
A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

France

3800+ trials
700+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Germany

3300+ trials
1300+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Greece

900+ trials
100+ centers
Latest trial:
A study to evaluate the safety and effects of inebilizumab in children and adolescents with immunoglobulin G4-related disease

Guadeloupe

2 trials
0 centers

Hungary

1100+ trials
200+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Iceland

29 trials
5 centers
Latest trial:
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

Ireland

400+ trials
42 centers
Latest trial:
A study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis

Israel

0 trials
1 centers

Italy

3300+ trials
400+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Latvia

100+ trials
68 centers
Latest trial:
A study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension

Lithuania

200+ trials
75 centers
Latest trial:
A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Luxembourg

7 trials
3 centers
Latest trial:
Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly Patients or Those at Risk of Bleeding After Balloon Surgery

Norway

600+ trials
99 centers
Latest trial:
Study on Treatment for Colorectal Liver Metastases Using Heparin, Dexamethasone, and Floxuridine for Patients with Heavy Tumor Burden

Poland

2400+ trials
1000+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Portugal

700+ trials
99 centers
Latest trial:
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

Réunion

1 trials
7 centers
Latest trial:
Study on the Effectiveness and Safety of Chikungunya Vaccine (VLA-1553) for People at Risk of Severe Chikungunya in La Réunion

Romania

700+ trials
300+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Slovakia

400+ trials
300+ centers
Latest trial:
Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Slovenia

93 trials
19 centers
Latest trial:
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

Spain

4000+ trials
600+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Sweden

900+ trials
100+ centers
Latest trial:
Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

The Netherlands

2100+ trials
200+ centers
Latest trial:
PET Imaging Study for Large B-Cell Lymphoma Patients Using 89Zr-CED88004S Before and After CAR T-Cell Therapy

United Kingdom

1 trials
2 centers
Latest trial:
Study of Atropine Sulfate eye drops (0.

United States

1 trials
1 centers
Latest trial:
Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis